Fifteen years of taking clinical technology to market
We deliver commercial outcomes for the major players in global healthcare; from payers and providers to clinical AI, biotech and pharmaceutical companies, from development institutions to the investors behind them.
The record below spans consulting engagements delivered by the firm and senior operating mandates held by its principal since 2010; each is labelled. As is standard in consulting, client names are not disclosed. References are available under NDA.
An advisory-network mandate on the IFC's flagship matchmaking programme, held from New Delhi between 2016 and 2020. The programme brought international health technology companies into Indian and Brazilian health systems through structured, evaluated pilots designed to convert into commercial contracts. Programme-reported outcomes: 38 international companies matched with Indian and Brazilian providers, more than 40 pilots delivered (70 clinical sites in India alone), 22+ commercial contracts signed, over $14.5M raised by participating innovators during the programme, and one participant acquired for $102M. The pilot-to-contract methodology is now part of how we design every market entry.
A Head of Growth mandate at a global medical imaging AI company: building adoption across public health systems, hospital groups and multilateral programmes, from disease screening programmes in emerging markets to enterprise deployments in mature ones. The lesson that became our thesis: the constraint was never the model.
A CMO and Head of Clinical Analytics mandate at a clinical analytics company: strengthening the commercial proposition, enterprise pipeline and clinical credibility ahead of the company's subsequent acquisition by a leading digital health platform.
A Chief Medical Information Officer mandate at a connected health company: shaping clinical strategy and enterprise positioning prior to the company's acquisition by one of Asia's largest conglomerates.
Commercial due diligence, investment readiness and portfolio value creation for healthcare investors, including operating partner mandates. Client identities and engagement details remain confidential; references available on request under NDA.
Commissioned to assess a leading Egyptian private hospital group ahead of investment, using Imperial College London's Healthcare Impact Framework and GIIN-aligned due diligence standards. The work combined site visits in Cairo, interviews across the C-suite, and independent analysis of affordability and patient mix that challenged management's own assumptions. Delivered impact findings, risks and a monitoring metrics framework adopted into the investment decision.
Across firm engagements, programme roles and advisory work since 2010, HealthCursor has delivered engagements for institutions including a Nordic development finance institution, the Ministries of Health of Malaysia and Tanzania (the latter alongside the US CDC), the United Nations Foundation, the Government of Canada's CIRCE programme, and global life sciences companies including Eli Lilly. It has additionally held programme, jury and advisory roles with the IFC World Bank, the GSMA and bodies across the World Health Organization ecosystem.
Engagements span 2010 to the present. Client references and detailed credentials are available on request.
Combined track record of HealthCursor and its founder since 2010.
It won't take long. Give us a few minutes to describe your needs and we'll get back to you shortly.
Contact UsRegistered Office
14/2E Docklands Business Centre
10-16 Tiller Road, London E14 8PX
Fifteen years of delivery in India,
including the IFC TechEmerge
programme from New Delhi
Market entry and government
engagement across the Gulf
through a partner network
Programme experience across
the United States, Brazil
and multilateral institutions